Tech Center 1600 • Art Units: 1611 1614 1615 1628 1641
This examiner grants 55% of resolved cases
Haejin S. Park is an examiner in Tech Center 1600 and Art Unit 1611, with 732 resolved cases. Her allowance rate of 54.9% indicates a moderate probability of success for patent applicants. This 54.9% rate suggests that slightly more than half of the applications result in a grant. The 732 resolved cases provide a robust statistical foundation for understanding the prosecution landscape in this art unit.
The median days to allowance for her cases is 1124. This 1124-day metric provides a benchmark for the time required to reach a successful resolution. For practitioners, the 1124 days to allowance is an important piece of information for managing client expectations and project timelines. This 1124-day figure reflects the typical pace of prosecution within Tech Center 1600 for this examiner.
The interview lift of 38.5% is quite high, suggesting that interviews are a very powerful tool for securing an allowance. This 38.5% lift indicates that applications are much more likely to be allowed following an interview with the examiner. Given the 54.9% base allowance rate, the 38.5% lift is a critical factor for practitioners to consider. Utilizing the 38.5% lift could be the most effective strategy for successfully navigating the 732 resolved cases in Art Unit 1611.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18239036 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Final Rejection | The University of North Carolina at Chapel Hill |
| 18695440 | COMPOSITIONS FOR USE | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18580859 | Reducing the Risk of Infection from Bacteria Present in Skin Pores During Surgery | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18713334 | SOLID POWDER COSMETIC PRODUCT | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18713382 | METAL COMPLEXED CYANURATE GERMICIDAL ADDITIVE FOR POLYMER COMPOSITIONS | Non-Final OA | SABIC Global Technologies B.V. |
| 18857684 | EMULSION WITH LIQUID CRYSTALLINE STRUCTURES | Non-Final OA | BEIERSDORF AG |
| 18608586 | ORALLY DISINTEGRATING NICOTINE TABLET FOR USE UNDER LIP | Final Rejection | Fertin Pharma A/S |
| 18685784 | METHOD FOR PRODUCING FILM | Final Rejection | KAO CORPORATION |
| 18687741 | ODOUR COUNTERACTION | Final Rejection | GIVAUDAN SA |
| 18713118 | TERNARY CO-AMORPHOUS FORMS OF DRUGS, PROTEINS, AND WATER-SOLUBLE POLYMERS | Non-Final OA | Zerion Pharma APS |
| 18295181 | COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION | Non-Final OA | Xygenyx Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy